The impact of genomics to identify novel immunotherapeutic targets in multiple myeloma

被引：0
|
作者：
Liu, Enze [1 ]
Sudha, Parvathi [1 ]
Abu Zaid, Mohammad [1 ]
Johnson, Travis [2 ]
Chopra, Vivek [3 ]
Dos Santos, Cedric [3 ]
Nixon, Michael [3 ]
Hamidi, Habib [3 ]
Suvannasankha, Attaya [4 ,5 ]
Lee, Kelvin [1 ]
Abonour, Rafat [6 ]
Walker, Brian [1 ]
机构：
[1] Indiana Univ, Sch Med, Div Hematol & Oncol, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA
[2] Indiana Univ, Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Roudebush VAMC, Indianapolis, IN USA
[6] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA-32
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [31] Novel drugs for the treatment of multiple myeloma: Mechanisms and targets
    Lentzsch, S.
    ONKOLOGIE, 2010, 33 : 19 - 19
  • [32] Low Dose Cyclophosphamide in Combination with Elotuzumab - a Novel Immunotherapeutic Strategy for Multiple Myeloma
    Feerick, Claire L.
    Lynch, Kevin
    Krawczyk, Janusz
    O'Dwyer, Michael
    Ryan, Aideen
    BLOOD, 2021, 138
  • [33] A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma
    Solli, Vincenza
    Poletti, Andrea
    Borsi, Enrica
    Martello, Marina
    Pantani, Lucia
    Armuzzi, Silvia
    Vigliotta, Ilaria
    Zamagni, Elena
    Tacchetti, Paola
    Rocchi, Serena
    Mancuso, Katia
    Mazzocchetti, Gaia
    Taurisano, Barbara
    Pistis, Ignazia
    Cavo, Michele
    Terragna, Carolina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S4 - S5
  • [34] Comparison of Human Genomics and Genetic Models of Cancer to Identify Novel Therapeutic Targets
    Armstrong, Scott A.
    Korsmeyer, Stanley J.
    CELL CYCLE, 2003, 2 (05) : 408 - 409
  • [35] Inverse genomics™ as a powerful tool to identify novel targets for the treatment of neurodegenerative diseases
    Rhoades, K
    Wong-Staal, F
    MECHANISMS OF AGEING AND DEVELOPMENT, 2003, 124 (01) : 125 - 132
  • [36] Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
    Hideshima, Teru
    Mitsiades, Constantine
    Tonon, Giovanni
    Richardson, Paul G.
    Anderson, Kenneth C.
    NATURE REVIEWS CANCER, 2007, 7 (08) : 585 - 598
  • [37] Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
    Teru Hideshima
    Constantine Mitsiades
    Giovanni Tonon
    Paul G. Richardson
    Kenneth C. Anderson
    Nature Reviews Cancer, 2007, 7 : 585 - 598
  • [38] Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
    Daniel E. Meyers
    Satbir Thakur
    Chandini M. Thirukkumaran
    Don G. Morris
    Blood Cancer Journal, 7
  • [39] Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
    Meyers, Daniel E.
    Thakur, Satbir
    Thirukkumaran, Chandini M.
    Morris, Don G.
    BLOOD CANCER JOURNAL, 2017, 7
  • [40] Functional genomics to identify therapeutic prophylactic targets
    Frank, Christian G.
    Bengoechea, Jose A.
    ENVIRONMENTAL MICROBIOLOGY REPORTS, 2010, 2 (02): : 219 - 227
12345